======= EIF4A2 =======
== Gene Information ==
* **Official Symbol**: EIF4A2
* **Official Name**: eukaryotic translation initiation factor 4A2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1974|1974]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14240|Q14240]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EIF4A2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF4A2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601102|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.
|Helicase C|
|DEAD|
|negative regulation of RNA-directed 5-3 RNA polymerase activity|
|regulation of RNA-directed 5-3 RNA polymerase activity|
|eukaryotic translation initiation factor 4F complex|
|cytoplasmic translational initiation|
|helicase activity|
|translation initiation factor activity|
|RNA helicase activity|
|cytoplasmic stress granule|
|cytoplasmic translation|
|regulation of translational initiation|
|cellular response to leukemia inhibitory factor|
|response to leukemia inhibitory factor|
|translational initiation|
|ATPase activity|
|negative regulation of transferase activity|
|regulation of translation|
|translation|
|regulation of cellular amide metabolic process|
|peptide biosynthetic process|
|posttranscriptional regulation of gene expression|
|amide biosynthetic process|
|peptide metabolic process|
|perinuclear region of cytoplasm|
|viral process|
|symbiotic process|
|cellular amide metabolic process|
|negative regulation of catalytic activity|
|interspecies interaction between organisms|
|regulation of transferase activity|
|cellular response to cytokine stimulus|
|response to cytokine|
|negative regulation of molecular function|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|RNA binding|
|organonitrogen compound biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|ATP binding|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.84|
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|7.88|
^Gene^Correlation^
|[[:human genes:c:ccar1|CCAR1]]|0.418|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18193
* **Expression level (log2 read counts)**: 9.6
{{:chemogenomics:nalm6 dist.png?nolink |}}